Maven Securities LTD - GILEAD SCIENCES INC ownership

GILEAD SCIENCES INC's ticker is and the CUSIP is 375558903. A total of 12 filers reported holding GILEAD SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of GILEAD SCIENCES INC
ValueSharesWeighting
Q3 2023$1,925,958
+2.8%
25,700
+5.8%
0.02%
-21.4%
Q2 2023$1,872,878
-4.8%
24,300
+2.5%
0.03%
-31.7%
Q1 2023$1,966,389
-6.7%
23,700
-4.0%
0.04%
-14.6%
Q4 2022$2,106,476
+126.0%
24,700
+63.6%
0.05%
+182.4%
Q3 2022$932,000
+947.2%
15,100
+906.7%
0.02%
+466.7%
Q1 2022$89,000
-76.4%
1,500
-72.2%
0.00%
-75.0%
Q3 2021$377,000
-12.9%
5,400
-21.7%
0.01%
-66.7%
Q3 2020$433,000
+101.4%
6,900
+146.4%
0.04%
+140.0%
Q2 2020$215,0002,8000.02%
Other shareholders
GILEAD SCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
PFM Health Sciences, LP 963,700$67,314,0001.98%
PURA VIDA INVESTMENTS, LLC 150,000$10,478,0000.32%
Capital Markets Trading UK LLP 245,200$17,394,0000.23%
GROUP ONE TRADING, L.P. 1,338,800$93,515,0000.10%
SIMPLEX TRADING, LLC 757,000$52,331,0000.05%
Marathon Trading Investment Management LLC 4,000$279,0000.02%
Maven Securities LTD 5,400$377,0000.01%
Allianz Asset Management GmbH 70,900$4,952,0000.00%
JPMORGAN CHASE & CO 155,900$10,890,0000.00%
CIBC WORLD MARKETS CORP 2,000$140,0000.00%
View complete list of GILEAD SCIENCES INC shareholders